The old website was not in sync with the company’s business strategy, offering, and value creation. Perhaps the new site will also help investors, in addition to customers, understand the company’s potential and its protected, leading competitive position?
5 Likes
A small bump like that from 100k shares traded doesn’t really tell us anything other than Nightingale’s momentum has developed through a long and continuous flow of good news to the point where the worst selling pressure has, at least for now, eased.
Even a little bit of extra interest on top of the daily small-time day traders is immediately reflected as a rise in the share price.
Teemu Suna gave his presentation today at the Radical Health fair from 1:00 PM – 2:30 PM. A slight upward nudge started around noon. Perhaps Teemu got a couple or three (small) investors interested in the story over lunch coffee before his talk and they put a few tens of thousands each into the stock.
I wouldn’t be surprised, as it’s quite easy to get excited by Teemu’s talks. That happened to me 3 years ago =).
Tomorrow, Wednesday, from 3:30 PM – 4:45 PM, Ilse Rauhaniemi from Terveystalo will give a presentation.
It’s quite interesting to see if a professional speaking from outside the company can add a little more wind to the sails of excitement.
Of course, larger gains still require real news about big contracts and partners, as well as possible new geographical expansions. And I suppose still that FDA approval too.
We’re only in the first quarter here. The game is still long, and there’s no need for hasty Hail Mary lunges.
13 Likes
According to the program, it’s tomorrow in the early evening. Furthermore, this is not an investor event, but one aimed at healthcare professionals.
2 Likes
Yep, the second of Teemu’s presentations (Closing Act) seems to be tomorrow, Wednesday, at 17:00 - 18:15.
In my message, I was mainly aiming for a response to the writer wondering about the small jump on non-existent volume. It only takes a couple or a few (retail) investors deciding to jump in, and the share price moves quickly. Nightingale’s momentum (with the favorable news flow) has become completely different from what it was, for example, last late autumn/winter. As well as the couple of years preceding it.
Thanks for the good points @Puutaheinaa !
4 Likes
https://www.koreabiomed.com/news/articleView.html?idxno=24106
Gradually after the fests, awareness of this is starting to spread through news coverage.
8 Likes
““This technology is used nationwide in Finland right now,” Suna said, noting that 30 percent of the workforce in Finland nationwide is being already screened with this technology routinely.”
The reporter has probably taken a bit of an optimistic stance here.
“The share of privately produced healthcare is 28 percent, or approximately 4.5 billion euros, which includes publicly funded and privately produced as well as privately produced and funded healthcare. The privately produced market relevant to Terveystalo includes occupational healthcare, primary healthcare, oral health, specialized medical care, and child welfare. Terveystalo’s share of this market is approximately 25–30 percent.”
And NGH then tests some portion of this occupational healthcare.
3 Likes
Finland has a unique occupational healthcare system with approximately 1.9 million Finnish customers. Occupational healthcare is linked to the statutory pension system; the system encourages employers to invest in occupational health to reduce pension costs. This has an impact on both public health and total healthcare costs. Terveystalo has more than 27,000 corporate customers in Finland, covering approximately 680,000 occupational health members.
If these figures are correct, Terveystalo’s share of employees covered by the occupational healthcare system is approximately 35%. Nightingale’s test has been implemented as an integral part of Terveystalo’s occupational healthcare service and covers all of their occupational health customers. Naturally, not everyone has been tested yet in such a short period of time, although they nominally belong to the group to be tested.
https://stat.fi/julkaisu/cln01x1oukcgd0cutlb21ovup
There were an average of 2,628,000 employed persons aged 15–74 in 2023
If the number of employed persons is used as a reference, the share of those covered by Terveystalo’s testing is around 25–26%. The scale is quite broad depending on which figures are used. However, the share is significant.
11 Likes
An interesting change to the stock option program – the duration of the employee option program was extended, while other terms remained unchanged. The options become exercisable once the company’s market cap reaches 5x and 10x (roughly) the current level. A large portion of the options are unused, and they intend to use these to incentivize new hires.
Does the board still think that those valuation growth limits are an okay incentive? If so, it’s either quite exciting, or they’re completely out to lunch 
10 Likes
This obviously cannot be true. Health check-up activities are carried out on a significantly smaller scale today than, for example, 10 years ago. A large number of companies do not conduct a single health check-up — only the statutory ones, when the employee’s work involves so-called exposures. For example, for knowledge workers, in the big picture, there is no obligation to carry out health checks.
In addition, health checks today involve a lot of discretion regarding both the necessity of a face-to-face meeting and the use of diagnostics. A pre-survey is used to screen whether there is a need to conduct any other investigations in addition to the survey.
My own rough estimate is that NGH tests could at best reach 20,000–30,000 units on an annual level.
2 Likes
In this pre-festival interview, Rauhaniemi claims the volume at Terveystalo was 30,000 in ten weeks.
23 Likes
A snippet from LinkedIn and Ilse Rauhaniemi’s presentation. Apparently, the test has already been administered to 70,000 people in five months…
25 Likes
Now it seems the matchstick used as a calculation tool is coming up a bit short.
Which is, of course, a fantastic thing =).
Hopefully, we’ll soon get a press release about the first 100K tests conducted by Terveystalo.
Even that 70,000 is quite a surge. It shows that this can be done in large volumes as part of customers’ everyday healthcare.
And Terveystalo is just one operator on this tiny strip of land that is an extension of Siberia.
If this really works as well as we’ve been told over the past three years, it will be anything but just a tool used for scouring biobanks, providing joy mainly to shaking academic fuddy-duddies.
Edit: Added an emoji. I didn’t mean to sound condescending. I am genuinely happy about these figures, as even my own previous most optimistic forecasts just started looking quite childish.
15 Likes
Stay tuned, says that Terveystalo representative over on LinkedIn. Only the beginning and more to come…
" We had some breaking news. We are bringing health promotion to a whole new level at Terveystalo and this is just the beginning!
We are looking forward to new perspectives on the future health status.
Stay tuned! 
"
10 Likes
It’s certainly true that if the test has been found in the occupational health sector to be even half as good as they’ve been hyping it up, there’s no reason not to expand its use to other OH (occupational health) activities as well.
5 Likes
The key thing is that TT is now a partner developing clinical practices and ways of creating value for NH’s main product within occupational health. These can then presumably be leveraged as sales tools and references globally.
12 Likes
Isn’t this so-called risk test by NH mainly about primary prevention, meaning that the utility of the test compared to other alternatives will only be seen after decades of follow-up? How on earth can anyone say anything at all about the utility of the test in this timeframe?
1 Like
If this is cost-effective enough to replace traditional tests as well, why couldn’t it be used more widely if the logistics etc. are already in place. It’s not like it has to predict death with every needle prick.
2 Likes
Could someone still explain how this is more cost-effective than the so-called traditional risk assessment and how this test is used in clinical practice? I strongly doubt that the old risk markers, e.g., blood sugar, lipids, etc., wouldn’t also be measured.
Or is it just a matter of being able to buy bulk lab tests cheaper through NH?
I don’t quite fully understand why the details aren’t being discussed at all.
Reporting and all other fact-based information have been very minimal over time, so it’s hard to say. That’s why one can only toss out guesses for and against off the cuff. But I’m sure at some point, even us “Average Joes” will be enlightened, and we’ll see who guessed right.
It has been known throughout the ages: don’t smoke, don’t drink too much, exercise, get enough sleep, eat healthy, etc. Apparently, business can be made by turning these self-evident truths into concrete blood values, presented to the “rehabilitant” as numerical facts right before their eyes. On the other hand, are people unable to understand what’s best for them, or is a healthy lifestyle simply not interesting in a world of pleasures?
9 Likes